Abstract:Background: The heart grows in response to pathological and physiological stimuli. The former often precedes cardiomyocyte loss and heart failure; the latter paradoxically protects the heart and enhances cardiomyogenesis. The mechanisms underlying these differences remain incompletely understood. Although long noncoding RNAs (lncRNAs) are important in cardiac development and disease, less is known about their roles in physiological hypertrophy or cardiomyogenesis. Methods: RNA sequencing was applied to hearts from mice after 8 weeks of voluntary exercise-induced physiological hypertrophy and cardiomyogenesis or transverse aortic constriction for 2 or 8 weeks to induce pathological hypertrophy or heart failure. The top lncRNA candidate was overexpressed in hearts with adeno-associated virus vectors and inhibited with antisense locked nucleic acid-GapmeRs to examine its function. Downstream effectors were identified through promoter analyses and binding assays. The functional roles of a novel downstream effector, dachsous cadherin-related 2 (DCHS2), were examined through transgenic overexpression in zebrafish and cardiac-specific deletion in Cas9-knockin mice. Results: We identified exercise-regulated cardiac lncRNAs, called lncExACTs. lncExACT1 was evolutionarily conserved and decreased in exercised hearts but increased in human and experimental heart failure. Cardiac lncExACT1 overexpression caused pathological hypertrophy and heart failure; lncExACT1 inhibition induced physiological hypertrophy and cardiomyogenesis, protecting against cardiac fibrosis and dysfunction. lncExACT1 functioned by regulating microRNA-222, calcineurin signaling, and Hippo/Yap1 signaling through DCHS2. Cardiomyocyte DCHS2 overexpression in zebrafish induced pathological hypertrophy and impaired cardiac regeneration, promoting scarring after injury. In contrast, murine DCHS2 deletion induced physiological hypertrophy and promoted cardiomyogenesis. Conclusions: These studies identify lncExACT1-DCHS2 as a novel pathway regulating cardiac hypertrophy and cardiomyogenesis. lncExACT1-DCHS2 acts as a master switch toggling the heart between physiological and pathological growth to determine functional outcomes, providing a potentially tractable therapeutic target for harnessing the beneficial effects of exercise.

Cooperative Interaction between the Basic Helix-loop-helix Transcription Factor dHAND and Myocyte Enhancer Factor 2C Regulates Myocardial Gene Expression

Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.

Cooperative Regulation of Zhx1 and Hnrnpa1 Drives the Cardiac Progenitor-Specific Transcriptional Activation During Cardiomyocyte Differentiation

The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming

Contraction-induced endocardial id2b plays a dual role in regulating myocardial contractility and valve formation

The evolutionary ancient MEIS transcription factors actuate lineage-specific transcription to establish cardiac fate

Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.

The Lncrna Hand2os1/Uph Locus Orchestrates Heart Development Through Regulation of Precise Expression of Hand2

The long noncoding RNA<i>Hand2as</i>orchestrates heart development through regulation of precise expression of<i>HAND2</i>

The Mechanism of Myocardial Hypertrophy Regulated by the Interaction Between Mhrt and Myocardin.

Insight into the regulatory mechanism of dynamic chromatin 3D interactions during cardiomyocyte differentiation in Human

lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth

Myocardin-Related Transcription Factor-A Induces Cardiomyocyte Hypertrophy

Cardiac Gene Activation Analysis in Mammalian Non-Myoblasic Cells by Nkx2-5, Tbx5, Gata4 and Myocd

Regulation Of Dhand Protein Expression By All-Trans Retinoic Acid Through Et-1/Etar Signaling In H9c2 Cells

The long noncoding RNA Hand2as orchestrates heart development through regulation of precise expression of HAND2

Landscape of Enhancer-Enhancer Cooperative Regulation During Human Cardiac Commitment

Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow/cardiac troponin C gene

Co-Occupancy By Multiple Cardiac Transcription Factors Identifies Transcriptional Enhancers Active In Heart

Interaction of cardiac transcription factor Nkx2.5 and GATA4

The transcription factor EBF1 non-cell-autonomously regulates cardiac growth and differentiation